We are live on
!
Find out more
ACM
American Capital Management Portfolio holdings
AUM
$1.86B
1-Year Est. Return
20.23%
This Fund
S&P 500
This Quarter
Est. Return
+13.71%
1 Year Est. Return
+20.23%
3 Year Est. Return
+63.07%
5 Year Est. Return
+75.1%
10 Year Est. Return
+632.65%
AUM
$1.3B
AUM Growth
+$92.5M
(+7.6%)
Cap. Flow
-$26.3M
Cap. Flow
% of AUM
-2.02%
Top 10 Holdings %
Top 10 Hldgs %
40.04%
Holding
172
New
64
Increased
5
Reduced
15
Closed
78
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Manhattan Associates
MANH
|
+$79.8M |
| 2 |
Cognex
CGNX
|
+$55.1M |
| 3 |
ResMed
RMD
|
+$44.6M |
| 4 |
HOLX
Hologic
HOLX
|
+$43.4M |
| 5 |
Gentex
GNTX
|
+$40.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Idexx Laboratories
IDXX
|
+$7.41M |
| 2 |
Liberty Global Class C
LBTYK
|
+$3.37M |
| 3 |
ICF International
ICFI
|
+$2.89M |
| 4 |
Icon
ICLR
|
+$1.49M |
| 5 |
AngioDynamics
ANGO
|
+$1.21M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 33.99% |
| 2 | Technology | 32.21% |
| 3 | Industrials | 12.24% |
| 4 | Financials | 6.69% |
| 5 | Consumer Discretionary | 5.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GWR
76
DELISTED
Genesee & Wyoming Inc.
GWR
| $745K | 0.06% |
+10,800
| New | +$708K |
|
77
iShares Global Tech ETF
IXN
$8.83B
| $592K | 0.05% |
+32,100
| New | +$567K |
|
|
NUVA
78
DELISTED
NuVasive, Inc.
NUVA
| $463K | 0.04% |
+6,950
| New | +$443K |
|
79
Bristol-Myers Squibb
BMY
$132B
| $399K | 0.03% |
+7,400
| New | +$475K |
|
80
Apple
AAPL
$4.57T
| $376K | 0.03% |
+13,300
| New | +$352K |
|
81
ExxonMobil
XOM
$634B
| $351K | 0.03% |
4,020
| – | – |
|
|
AIOT
82
PowerFleet Inc
AIOT
$592M
| $342K | 0.03% |
+69,200
| New | +$347K |
|
83
Berkshire Hathaway Class B
BRK.B
$1.13T
| $253K | 0.02% |
+1,754
| New | +$257K |
|
84
GE Aerospace
GE
$384B
| $251K | 0.02% |
+1,769
| New | +$264K |
|
85
Graham Corp
GHM
$1.31B
| $204K | 0.02% |
+10,660
| New | +$201K |
|
86
Pool Corp
POOL
$7.5B
| $203K | 0.02% |
2,150
| – | – |
|
|
87
AngioDynamics
ANGO
$649M
| – | – |
-84,000
| Closed | -$1.21M |
|
|
88
ICF International
ICFI
$1.72B
| – | – |
-70,600
| Closed | -$2.89M |
|
89
Liberty Global Class A
LBTYA
$3.6B
| – | – |
-38,030
| Closed | -$1.1M |
|
|
90
Liberty Global Class C
LBTYK
$3.49B
| – | – |
-117,706
| Closed | -$3.37M |
|
91
Liberty Latin America Class C
LILAK
$1.64B
| – | – |
-11,388
| Closed | -$317K |
|
92
AT&T
T
$163B
| – | – |
-7,261
| Closed | -$237K |
|
93
Verizon
VZ
$196B
| – | – |
-4,614
| Closed | -$258K |
|
Similar funds
WRBC
CP
EAM
BCIM
SG
LPU
CFA
OFG
American Capital Management's Q3 2016 Portfolio in Review
As of Q3 2016, American Capital Management held 172 positions worth $1.3B, up 7.6% from $1.21B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
American Capital Management's Q3 2016 filing shows 64 new, 5 increased, 15 reduced and 78 closed positions. Its largest new stake was Manhattan Associates: 1,324,917 shares worth $76.3M. The largest sale was Idexx Laboratories, an estimated $7.41M.
By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 13% a quarter earlier, followed by Technology and Industrials.
- American Capital Management's largest Q3 2016 buy was Manhattan Associates: 1,324,917 shares worth $76.3M.
- American Capital Management added most to Blackbaud in Q3 2016, an estimated $5.43M increase.
- American Capital Management's biggest Q3 2016 reduction was Idexx Laboratories, cutting an estimated $7.41M.
- American Capital Management fully exited Liberty Global Class C in Q3 2016, selling an estimated $3.37M.
- American Capital Management's ten largest holdings make up 40% of its $1.3B portfolio in Q3 2016.
- American Capital Management opened 64 new positions and closed 78 in Q3 2016.
- American Capital Management's portfolio value rose 7.6% quarter-over-quarter to $1.3B.
Based on American Capital Management's 13F filing for Q3 2016, filed 26 Oct 2016.